| 201 |
21390563 | Is fibroblast growth factor 23 a harbinger of mortality in CKD? | 2012 May |
2 |
| 202 |
21730210 | Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. | 2012 Feb |
2 |
| 203 |
21898178 | Evaluation of a new automated chemiluminescence immunoassay for FGF23. | 2012 Mar |
2 |
| 204 |
21932165 | The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis. | 2012 Mar |
1 |
| 205 |
22025115 | Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients. | 2012 May |
1 |
| 206 |
22103239 | FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results. | 2012 Oct |
2 |
| 207 |
22121948 | Are fibroblast growth factor 23 concentrations in renal transplant patients different from non-transplanted chronic kidney disease patients? | 2012 Feb |
1 |
| 208 |
22140123 | Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol. | 2012 Jun |
1 |
| 209 |
22246283 | (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers. | 2012 Jan |
2 |
| 210 |
22247037 | Mechanism of FGF23 processing in fibrous dysplasia. | 2012 May |
2 |
| 211 |
22249518 | Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. | 2012 Jan 17 |
4 |
| 212 |
22293059 | A randomised clinical study of alfacalcidol and paricalcitol. | 2012 Feb |
1 |
| 213 |
22298654 | Regulation and function of the FGF23/klotho endocrine pathways. | 2012 Jan |
1 |
| 214 |
22393163 | 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes. | 2012 Mar |
1 |
| 215 |
22396160 | Klotho and βKlotho. | 2012 |
1 |
| 216 |
22396161 | FGF23 and syndromes of abnormal renal phosphate handling. | 2012 |
2 |
| 217 |
22396162 | Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis. | 2012 |
3 |
| 218 |
22396166 | FGF23 in chronic kidney disease. | 2012 |
2 |
| 219 |
22396168 | FGF23 as a novel therapeutic target. | 2012 |
1 |
| 220 |
22421513 | Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. | 2012 May 15 |
2 |
| 221 |
22493603 | A Case of Carcinoid Tumor-Associated Hypercalcemia. | 2012 Feb |
1 |
| 222 |
22523113 | FGF-23 and vitamin D: don't shoot the messenger? | 2012 Jun |
3 |
| 223 |
22606047 | Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease. | 2012 |
7 |
| 224 |
22700885 | FGF-23 levels in patients with AKI and risk of adverse outcomes. | 2012 Aug |
1 |
| 225 |
22703926 | Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). | 2012 Jul 17 |
2 |
| 226 |
22733815 | Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. | 2012 Aug 17 |
1 |
| 227 |
22739976 | Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites. | 2012 Nov |
2 |
| 228 |
22742720 | Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial. | 2012 Jun 28 |
3 |
| 229 |
22754549 | Parathyroid diseases and animal models. | 2012 |
1 |
| 230 |
22807503 | Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management. | 2012 Sep |
2 |
| 231 |
22848110 | FGF-23 in children with CKD: a new player in the development of CKD-mineral and bone disorder. | 2012 Dec |
3 |
| 232 |
22921424 | The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. | 2012 Dec |
2 |
| 233 |
22921867 | Fibroblast growth factor 23: state of the field and future directions. | 2012 Dec |
2 |
| 234 |
23023636 | [Phosphate sensing and osteocyte]. | 2012 Oct |
2 |
| 235 |
23108197 | Hypophosphatemic rickets. | 2012 Dec |
1 |
| 236 |
23128114 | Enhanced induction of Cyp24a1 by FGF23 but low serum 24,25-dihydroxyvitamin D in CKD: implications for therapy. | 2012 Nov |
1 |
| 237 |
23214203 | Fibroblast growth factor 23--structure, function and role in kidney diseases. | 2012 May-Jun |
1 |
| 238 |
23217254 | Circulating fibroblast growth factors as metabolic regulators--a critical appraisal. | 2012 Dec 5 |
1 |
| 239 |
23662440 | [Pathologies of calcium-phosphate homeostasis]. | 2012 |
1 |
| 240 |
23951494 | What's new in FGF23 research? | 2012 |
1 |
| 241 |
20966399 | Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. | 2011 Jan |
2 |
| 242 |
21292848 | Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? | 2011 Feb |
1 |
| 243 |
21383962 | Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. | 2011 Feb 12 |
6 |
| 244 |
21404002 | FGF23 in skeletal modeling and remodeling. | 2011 Jun |
2 |
| 245 |
21490240 | Tumor-induced osteomalacia. | 2011 Jun |
2 |
| 246 |
21496980 | Role of Klotho in aging, phosphate metabolism, and CKD. | 2011 Jul |
3 |
| 247 |
21497493 | [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism]. | 2011 Jun |
2 |
| 248 |
21504790 | Hormone-like fibroblast growth factors and metabolic regulation. | 2011 Jul |
1 |
| 249 |
21610497 | CYP24A1 and kidney disease. | 2011 Jul |
2 |
| 250 |
21611969 | Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. | 2011 Jun |
1 |